Patents Represented by Attorney Robert F. Chisholm
  • Patent number: 6783752
    Abstract: Ultrasonic visualisation of a suject, particularly of perfusion in the myocardium and other tissues, is performed using novel gas-containing contrast agent preparations which promote controllable and temporary growth of the gas phase in vivo following administration and can therefore act as deposited perfusion tracers. The preparations include a coadministerable composition comprising a diffusible component capable of inward diffusion into the dispersed gas phase to promote temporary growth thereof. In cardiac perfusion imaging the preparations may advantageously be coadministered with vasodilator drugs such as adenosine in order to enhance the differences in return signal intensity from normal and hypoperfused myocardial tissue respectively.
    Type: Grant
    Filed: December 5, 2001
    Date of Patent: August 31, 2004
    Assignee: Amersham Health AS
    Inventors: Jonny Østensen, Morten Eriksen, Sigmund Frigstad, Pål Rongved
  • Patent number: 6749554
    Abstract: A medical or surgical device or tool that is designed to be implanted or inserted inside the human or mammalian body, having at least part of its surface coated whereby the ultrasound visibility of said device or tool in vivo is enhanced, wherein the coating comprises one or more of the following: (i) a matrix material containing a plurality of contrast enhancing elements; (ii) magnesium; (iii) a liquid or polymer which alters its ultrasound imaging properties upon elevating the temperature from ambient to physiological temperature; (iv) a liquid or polymer which alters its ultrasound imaging properties as a result of a change in pH; (v) an essentially non-polymeric bio-compatible compound which forms a discontinuous coating. Preferably the device or tool is a radioactive source for use in brachytherapy, and in particular a radioactive seed.
    Type: Grant
    Filed: January 11, 2002
    Date of Patent: June 15, 2004
    Assignee: Amersham PLC
    Inventors: Robert Allen Snow, Henry Wolfe, Anna Rydbeck, Tore Gjorsvik, Steven Coffey, Hakan Malmgren, Oskar Axellson
  • Patent number: 6735977
    Abstract: An apparatus and a method for providing a magnetic holding field about a chamber for accumulating frozen 129Xe. The apparatus includes a magnetic field source and a yoke for supporting the magnetic field source about the chamber. The magnetic field source provides a magnetic holding field having a field strength of greater than 2 kiloGauss. The apparatus may further include yoke for coupling the magnetic holding field through a portion of the chamber.
    Type: Grant
    Filed: August 19, 2002
    Date of Patent: May 18, 2004
    Assignee: Medi-Physics, Inc.
    Inventors: Nicholas N. Kuzma, Ian Nelson
  • Patent number: 6730013
    Abstract: The present invention provides apparatus and methods for loading delivery systems, such as seed magazines and suture material, with seeds which greatly increases productivity, reduces process variation and reduces the risk of handling damage to the seeds. Importantly, the apparatus and methods of the present invention reduce potential risks to workers. In a first aspect of the invention there is provided an automated method of loading a delivery system for brachytherapy seeds which comprises the steps of a) securing the delivery system to be loaded; b) conmnunicating seeds from a supply of seeds into the delivery system; and c) repeating step b) to load a plurality of seeds. In a second aspect of the invention there is provided an apparatus for loading a delivery system for brachytherapy seeds comprising: a) means for retaining a delivery system to be loaded with seeds; and b) means for communicating individual seeds from a supply of seeds to said delivery system.
    Type: Grant
    Filed: April 8, 2003
    Date of Patent: May 4, 2004
    Assignee: Medi-Physics, Inc.
    Inventors: Charles E. Shank, John Mueller, Kevin Helle
  • Patent number: 6696040
    Abstract: An in vivo non-invasive method for detecting and/or diagnosing a pathological condition using hyperpolarized 129Xe spectroscopy is disclosed. Generally stated, the method includes determining the magnitude of spectral peaks which represent particular chemical shifts and comparing the observed magnitudes to those of healthy individuals. Preferably, the method includes subtracting substantial backgrounds and accounting for secondary conditions such as the polarization of hyperpolarized gas administered. Additionally, a quantitative analysis of hyperpolarized 129Xe spectra advantageously allows a physician to establish the extent of disease progression. Advantageously, this method can be used regardless of the method of hyperpolarized 129Xe administration.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: February 24, 2004
    Assignee: Medi-Physics, Inc.
    Inventor: Bastiaan Driehuys
  • Patent number: 6689065
    Abstract: Prostate abnormalities such as cancer may be detected by ultrasonic determination of the in-flow kinetics of contrast agent-containing blood in the prostate and/or by observation of disease-related asymmetries in the the spoke-like vascular pattern of the prostate.
    Type: Grant
    Filed: June 4, 2002
    Date of Patent: February 10, 2004
    Assignee: Amersham Health AS
    Inventors: Anne Kirsti Aksnes, Morten Eriksen, Else Kruger Hagen, Audun Tornes
  • Patent number: 6669622
    Abstract: A loader device, for dispensing implantation seeds from a seed magazine, comprising a body (3), seed magazine receiving and locating means (27,), seed dispensing means (37) for ejecting seeds from a seed magazine, and a seed-transporting path (17) leading to a dispensing outlet (8), which loader device further comprises a spacer-transporting path (29, 31, 33, 35) for transporting spacers through the device to the dispensing outlet (8).
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: December 30, 2003
    Assignee: Medi-Physics, Inc.
    Inventors: Jay C. Reed, Kevin M. Helle
  • Patent number: 6659296
    Abstract: A package (10) comprises a plastic bottle (20), a stopper (40) removably inserted into the mouth of the bottle, and a plastic cap (50). The cap has a cover member (52) which overlies the stopper and has a region (66) which is removable to expose the upper surface of the stopper to allow piercing thereof by a needle or the like. The removable region is provided with a pull-ring (68) protected from accidental operation by a protective portion (60) projecting upwardly from the edge of the cover member (52). The protective portion is formed separately from the rest of the cap and is attached thereto.
    Type: Grant
    Filed: January 23, 2001
    Date of Patent: December 9, 2003
    Assignee: Amersham Health AS
    Inventor: Martin Monteagle Browne
  • Patent number: 6646171
    Abstract: A process for the crystallisation of a sterically hindered organic compound from a saturated or supersaturated solution of said compound in a solvent therefor, characterised in that crystallisation is effected under elevated pressure at a temperature above the boiling point of said solution at atmospheric pressure and up to the boiling point of said solution at said elevated pressure.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: November 11, 2003
    Assignee: Amersham Health AS
    Inventor: Jan Cervenka
  • Patent number: 6562320
    Abstract: This invention relates to a freeze-dried vesicle containing ultrasound contrast agent containing a freeze-drying stabilizer and thermally stable at temperatures in excess of 20° C.
    Type: Grant
    Filed: June 26, 2000
    Date of Patent: May 13, 2003
    Assignee: Amersham Health AS
    Inventors: Marit Swaerd-Nordmo, Per Helge Gulliksen, Jorunn Undheim Braenden, Anne Kjersti Fahlvik
  • Patent number: 6548048
    Abstract: Novel membrane-forming amphiphilic lipopeptides comprising one or more peptide moieties containing 2-50 aminoacyl residues and one or more hydrocarbon chains containing 5-50 carbon atoms. Such lipopeptides may be used in the formation of stabilized gas microbubble dispersions suitable for use as diagnostic and/or therapeutic agents, for example as ultrasound contrast agents.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: April 15, 2003
    Assignee: Amersham Health AS
    Inventors: Alan Cuthbertson, Magne Solbakken, Henry Raphael Wolfe
  • Patent number: 6514480
    Abstract: To lessen the allergic or pseudoallergic side effects of radiological contrast agents, the contrast agent is preincubated in vitro with a reactive medium such as human or animal blood protein, whereupon the resultant reaction products are separated off from the contrast agent by ultrafiltration.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: February 4, 2003
    Assignee: Amersham Health AS
    Inventor: Bernhard Sixt
  • Patent number: 6509004
    Abstract: The invention provides a process for the preparation of a pharmaceutical composition comprising an aqueous dispersion of gas-containing vesicles the membranes whereof comprise an amphiphilic membrane-forming material, said process comprising: (i) generating a liquid dispersion of gas-containing vesicles from a mixture comprising an amphiphilic membrane forming material; (ii) lyophilizing a liquid dispersion of said gas-containing vesicles; (iii) reconstituting the lyophilized product of step (ii) with a sterile aqueous liquid to produce an aqueous dispersion of gas-containing vesicles; and (iv) treating the aqueous dispersion product of step (iii) or the lyophilized product of step (ii) to produce a substantially aggregate-free sterile aqueous dispersion of gas-containing vesicles.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: January 21, 2003
    Assignee: Amersham Health AS
    Inventors: Ingrid Henriksen, Vera Kasparkova, Arnfinn Andersen, Anne Kjersti Fahlvik, Liv Ingrid Odegardstuen
  • Patent number: 6500917
    Abstract: The invention provides an improved process for the synthesis of compounds carrying at least one phosphate group, especially polyalkylene glycol phosphate compounds, said process comprising the steps of: (a) reacting a compound containing at least one primary alcohol moiety with a diaryl- or diaralkyl-halophosphate whereby to form the corresponding diaryl- or diaralkyl-phosphate ester; (b) reductively cleaving the resulting product; and (c) if desired, repeating steps (a) and (b) with the product of step (b) whereby to produce a compound carrying two or more phosphate groups. Advantages of the process in accordance with the invention are that this avoids the production of by-products and results in products which are low in impurities. Also provided are novel diaryl- and diaralkyl-phosphate ester compounds, in particular polyethylene glycol diphenylphosphate ester and derivatives thereof.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: December 31, 2002
    Assignee: Amersham Health AS
    Inventors: Manohar Tukaram Saindane, David Lee Ladd
  • Patent number: 6474535
    Abstract: In a method for welding closed one end of each of a multiplicity of open-ended tubes suitable for use as brachytherapy capsules (100), each tube is loaded into a holder (52), brought to a welding station (80), has one end welded closed and is then released from the holder (52). A number of holders can 2 be arranged on the periphery of a rotatable member (50), each holder being loaded with a tube at a first station, and then carrying the tube to a welding station (80) and an ejection station (90). The tubes can be loaded into the holders individually by means of an escapement mechanism (40). The invention also extends to apparatus for carrying out the method.
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: November 5, 2002
    Assignee: Nycomed Imaging AS
    Inventors: Charles Shanks, Kevin Helle, John Krewer, Robert Hallgren
  • Patent number: 6468409
    Abstract: An apparatus for detecting fluorophore labelled substances in an electrophoretic separation medium comprises illuminating means (1) for illuminating the fluorophore labelled substances (8), detecting means (7) for detecting fluorescence emitted by said fluorophore labelled substances upon illumination, and illumination varying means (9) for varying the illumination of the fluorophore labelled substances (8) to vary the intensity of the fluorescence.
    Type: Grant
    Filed: September 13, 2000
    Date of Patent: October 22, 2002
    Assignee: Amersham Biosciences AB
    Inventors: Allan Asp, Bengt-Goran Andersson
  • Patent number: 6444193
    Abstract: The invention provides a process for the preparation of gas-containing vesicles wherein a mixture of gas, liquid and vesicle membrane forming material is passed through a zone in which it is subject to shear forces exerted by surfaces moving relative to each other at a speed of at least 20 m/s.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: September 3, 2002
    Assignee: Nycomed Imaging AS
    Inventors: Tore Omtveit, Bjorn Haugseter, Tony Pete
  • Patent number: 6441235
    Abstract: A process for preparing 5-amino-N,N′-bis(R)isophthalamides, where A is 2,3-dihydroxypropyl or 1,3-dihydroxyisopropyl, useful as intermediates in preparing iodinated diagnostic agents, which comprises reacting a di-lower-alkyl 5-nitroisophthalate with a compound of the formula RNH2 in the presence of a basic catalyst and without isolating the intermediate 5-nitro-N,N′-bis(R)isophthalamide, catalytically hydrogenating the latter.
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: August 27, 2002
    Assignee: Amersha, Health AS
    Inventors: Edward David Parady, Karl Olaf Gelotte
  • Patent number: 6428479
    Abstract: Prostate abnormalities such as cancer may be detected by ultrasonic determination of the in-flow kinetics of contrast agent-containing blood in the prostate and/or by observation of disease-related asymmetries in the spoke-like vascular pattern of the prostate.
    Type: Grant
    Filed: June 19, 2000
    Date of Patent: August 6, 2002
    Assignee: Nycomed Imaging AS
    Inventors: Anne Kirsti Aksnes, Morten Eriksen, Else Kruger Hagen, Audun Tornes
  • Patent number: 6428707
    Abstract: A method for adsorption of a substance from a liquid sample on a fluidized bead or stirred suspension, in which the beads used comprise a base matrix and exhibit a structure having affinity to the substance, characterized in that the structure is covalently bound to the base matrix via an extender. Populations of beads in which the beads contain a filler incorporated in a base matrix and an extender are also described.
    Type: Grant
    Filed: March 13, 2000
    Date of Patent: August 6, 2002
    Assignee: Amersham Pharmacia Biotech AB
    Inventors: Hans Berg, Hasse Hansson, Lennart Kagedal